Inflammation- and immunity-related proteins

Inflammation- and immunity-related proteins represent a vast and heterogeneous group of molecules, including cytokines, chemokines, and receptors, that coordinate the body's response to injury and pathogens (Source: Nature Reviews Immunology). These proteins, such as Tumor Necrosis Factor (TNF) and various Interleukins, act as critical signaling mediators that regulate the activation and trafficking of immune cells (Source: UniProt). While essential for host defense, the chronic dysregulation of these proteins is a primary driver of autoimmune diseases, chronic inflammatory conditions, and "cytokine storms" (Source: NIH). Therapeutic strategies targeting these proteins often involve monoclonal antibodies or small molecule inhibitors designed to suppress overactive immune responses (Source: PubMed). Because of their central role in immunity, modulating these targets requires a careful balance to avoid excessive immunosuppression and increased vulnerability to infections (Source: FDA).

Other names

Immune system proteinsInflammatory mediatorsCytokines and chemokinesImmunomodulatory proteinsInflammation-related proteins

Therapeutic agents targeting this broad class of proteins employ diverse mechanisms, including the direct neutralization of circulating cytokines (e.g., TNF-alpha inhibitors), competitive antagonism of cell-surface receptors (e.g., IL-6 receptor blockers), and the inhibition of downstream intracellular signaling enzymes such as Janus kinases (JAKs) to prevent gene transcription associated with inflammation (Source: PubMed, StatPearls).